Commentary · 21 Feb 2026
Conference abstractPublished 26 Sep 2016
Cardiovascular toxicity by anticancer therapy (chemotherapy, radiotherapy, targeted agents): Utility of early diagnosis and extended cardiological follow up
Regina Elena National Cancer Institute, Italy
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Anticancer treatment with chemotherapy, radiotherapy and targeted agents can lead to heart damages. Cardiotoxicity has a serious clinical and prognostic impact on cancer patients, and early identification is essential in order to start preventative therapy and cardiac support. The conventional tools currently being used for the diagnosis of cardiotoxicity (ECG and conventional echocardiographic study) do not permit early diagnosis of cardiotoxicity. The early diagnosis of cardiotoxicity induced by anticancer therapies is possible with a new approach based on the use of cardiac biomarkers, in particular troponins and with advanced echocardiography. In cancer patients, we can observe radiotherapy and chemotherapy heart damages even after many years. Cancer patient is a chronic patient and frequently requires prolonged, repeated anticancer therapies and repeated interventions of oncologic surgery during the course of his disease. The perioperative cardiologic management it can determine changes that can take time, the consequent delay of the planned surgery to allow the assessment and significant changes in cardiologic management, will negatively affect outcome also with a negative impact on the costs for the time extension of the hospitalization. In cancer patients, we recommend the cardiologic surveillance, also for several years, after radiotherapy and chemotherapy to detect and treat in time heart damages to avoid delays in case of future oncologic timesensitive surgery.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Cancer Science & Therapy.
Perspective · 21 Feb 2026
Finding Potential Passerini Adducts for Anticancer Drug Development
Perspective · 21 Feb 2026
Head and Neck Cutaneous Squamous Cell Carcinoma with Perineural Invasion
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCancer Science & Therapy
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Fabio Maramao”
